简体中文

论著-头颈部

药物性肝损伤患者 的临床特点及CT影 像学表现分析

作者:赵向前1 董 菁2

所属单位:1.解放军第一五二中心医院感染科 (河南 平顶山 467000) 2.郑州大学第五附属医院体检科 (河南 郑州 450000)

PDF

摘要

目的 分析85例药物性肝损伤 (DILI)患者的临床特点及CT影像学表 现,以期为临床预防、诊治提供参考。 方法 全部病例资料来源于2010年1月至 2018年7月我院确诊的DILI患者,共计 85例,对所有患者性别、年龄、病史、 用药史、临床特征、临床分型及肝功能 生化指标、CT检查结果等进行回顾性分 析。结果 本组患者男女比例为1:1.18, 以41-60岁年龄段居多,占73.75%;临 床表现以纳差、乏力、上腹部不适、食 欲下降最为常见。DILI患者中,三种以 上联合用药占比最高,其次为中药、抗 生素类药、抗病毒药、非甾体抗炎药。 DILI临床分型以肝细胞型为主,其次为 胆汁淤积型,混合型最少。肝细胞型 DILI混合型丙氨酸氨基转移酶(ALT)、天 冬氨酸氨基转移酶 (AST)水平明显高于 胆汁淤积型(P<0.05),三种分型谷氨酰 转移酶(GGT)无明显差异(P>0.05)。CT 显示DILI类型以弥漫性肝损伤、局灶性 肝损伤为主,分别占52.94%、43.53%, 多灶性肝损伤较少见,仅占3.53%;三 者CT值依次为31-42Hu、41-49Hu、45- 51Hu,CT依次显示为肝实质密度降低、 多发小片状低密度病灶、多灶性低密度 斑片影。结论 ①DILI可发生于各年龄段 人群,临床表现无特异性,引起DILI的 药物种类繁多,故临床使用药物治疗疾 病时应注重用药安全;②DILI临床分型 多为肝细胞损伤型,CT影像表现具有一 定特征,对临床诊断有一定参考价值。

Objective To analyze the clinical features and CT imaging findings of 85 patients with drug-induced liver injury (DILI)to provide references for clinical prevention, diagnosis and treatment. Methods A total of 85 patients with DILI diagnosed in the hospital from January 2010 to July 2018 were included in the study. Gender, age, medical history, medication history, clinical features, clinical classification, biochemical indicators of liver function and CT findings were analyzed retrospectively. Results The ratio of male to female in this study was 1:1.18, and most patients were between 41 and 60 years old, accounting for 73.75%. The most common clinical manifestations included poor appetite, fatigue, upper abdominal discomfort and loss of appetite. Among the patients with DILI, the proportion of three or more combinedmedication was the highest, followed by traditional Chinese medicines, antibiotics, antiviral drugs and non-steroidal anti-inflammatory drugs. The main clinical type of DILI was hepatocyte type, followed by cholestasis typeand the mixed type. The levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in hepatocytetype and mixed type were significantly higher than those in cholestasis type (P<0.05), but there was no significant difference in the level of glutamyl transferase (GGT) among the three types (P>0.05). CT showed that main types of DILI were diffuse liver injury and focal liver injury, accounting for 52.94% and 43.53%, respectively. Multifocal liver injury was rare, accounting for only 3.53%. The CT number of the them were 31~42Hu, 41~49Hu and 45~51Hu, respectively. CT showed decreased liver parenchyma density, multiple small patchy low-density lesions and multifocal low-density patchy shadow. Conclusion DILI occur in all ages, and the clinical manifestations are not specific. The drugs causing DILI are various. Therefore, clinical use of drugs should focus on medication safety when treating diseases. The main clinical type of DILI is hepatocyte injury, and the CT image is characteristic, which is of certain reference value for clinical diagnosis.

【关键词】药物性肝损伤;临床特点; CT;影像学表现

【中图分类号】R57;R73

【文献标识码】A

【DOI】10.3969/j.issn.1672- 5131.2019.03.026

前言

世界范围内,药物性肝损伤(Drug-induced liver injury,DILI) 是药物研发被迫中断与上市药物撤市的重要原因[1]。药物性肝损伤作 为临床常见的最严重的药物不良反应之一,近年来,国内DILI的发病 率随着制药技术的不断提升、新药的不断问世及人们健康观念的变化, 所报道的发病率逐年上升[2]。既往报道[3-4]显示,DILI占所有药物不良 反应的10%~15%,其中有10%的急性DILI患者可进展为严重肝病或暴发 性肝衰竭,甚至可危及生命。由于DILI的临床表现与病理特征均缺乏 特异性,与急、慢性肝病具有相似性,加之尚无简便、客观、敏感的 诊断指标,亦缺乏特效治疗方法,总结与分析DILI的发病特点、致病 原因及影像学表现对早期发现、早期诊断及早期治疗DILI具有重要的 临床意义。本研究回顾性分析我院2010年1月至2018年7月确诊的85例 DILI患者的各项资料,分析其临床特点及CT影像学表现,以期为临床 预防、诊治提供借鉴。